Berkenblit Anna 4
4 · ImmunoGen, Inc. · Filed Feb 9, 2021
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Berkenblit Anna
VP & Chief Medical Officer
Transactions
- Award
Common Stock (right to buy)
2021-02-05$7.69/sh+282,019$2,168,726→ 282,019 totalExercise: $7.69From: 2022-02-05Exp: 2031-02-05→ Common Stock (282,019 underlying)
Footnotes (1)
- [F1]These options vest over a four-year period, with 25% of the shares vesting on the one year anniversary of the date of grant, and thereafter an additional 6.25% of the shares vesting on each succeeding quarterly anniversary of the date of grant.